155 related articles for article (PubMed ID: 20333420)
1. Biological activity of enantiomeric complexes [PtCl(2)L (2)] (L (2) is aromatic bisphosphanes and aromatic diamines).
Bombard S; Gariboldi MB; Monti E; Gabano E; Gaviglio L; Ravera M; Osella D
J Biol Inorg Chem; 2010 Aug; 15(6):841-50. PubMed ID: 20333420
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological studies of pyrazolyl-diamine Pt(II) complexes containing polyaromatic DNA-binding groups.
Gama S; Mendes F; Esteves T; Marques F; Matos A; Rino J; Coimbra J; Ravera M; Gabano E; Santos I; Paulo A
Chembiochem; 2012 Nov; 13(16):2352-62. PubMed ID: 23038670
[TBL] [Abstract][Full Text] [Related]
3. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
4. Linking of Antitumor trans NHC-Pt(II) Complexes to G-Quadruplex DNA Ligand for Telomeric Targeting.
Betzer JF; Nuter F; Chtchigrovsky M; Hamon F; Kellermann G; Ali S; Calméjane MA; Roque S; Poupon J; Cresteil T; Teulade-Fichou MP; Marinetti A; Bombard S
Bioconjug Chem; 2016 Jun; 27(6):1456-70. PubMed ID: 27115175
[TBL] [Abstract][Full Text] [Related]
5. Pd(II) and Pt(II) complexes with aromatic diamines: study of their interaction with DNA.
Pérez-Cabré M; Cervantes G; Moreno V; Prieto MJ; Pérez JM; Font-Bardia M; Solans X
J Inorg Biochem; 2004 Mar; 98(3):510-21. PubMed ID: 14987853
[TBL] [Abstract][Full Text] [Related]
6. Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines.
Gabano E; Gama S; Mendes F; Gariboldi MB; Monti E; Bombard S; Bianco S; Ravera M
J Biol Inorg Chem; 2013 Oct; 18(7):791-801. PubMed ID: 23873259
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of the enantiomeric R- and S-1,1'-binaphthyl-2,2'-diaminodichlorido-Pt(ii) complexes in human Burkitt lymphoma cells: emphasis on cellular accumulation, cytotoxicity, DNA binding, and ability to induce apoptosis.
Sørensen BH; Werth P; Lambert IH; Bednarski PJ
Metallomics; 2018 Feb; 10(2):323-336. PubMed ID: 29333543
[TBL] [Abstract][Full Text] [Related]
8. Platinum(II) phenanthroimidazoles for targeting telomeric G-quadruplexes.
Castor KJ; Mancini J; Fakhoury J; Weill N; Kieltyka R; Englebienne P; Avakyan N; Mittermaier A; Autexier C; Moitessier N; Sleiman HF
ChemMedChem; 2012 Jan; 7(1):85-94. PubMed ID: 22052801
[TBL] [Abstract][Full Text] [Related]
9. Study on Antitumor Platinum(II) Complexes of Chiral Diamines with Dicyclic Species as Steric Hindrance.
Liu F; Gou S; Chen F; Fang L; Zhao J
J Med Chem; 2015 Aug; 58(16):6368-77. PubMed ID: 26247573
[TBL] [Abstract][Full Text] [Related]
10. Exclusive platination of loop adenines in the human telomeric G-quadruplex.
Bertrand H; Bombard S; Monchaud D; Talbot E; Guédin A; Mergny JL; Grünert R; Bednarski PJ; Teulade-Fichou MP
Org Biomol Chem; 2009 Jul; 7(14):2864-71. PubMed ID: 19582295
[TBL] [Abstract][Full Text] [Related]
11. New platinum(II) complexes targeting the loops of the human telomeric G-quadruplex.
Bertrand H; Bombard S; Monchaud D; Teulade-Fichou MP
Nucleic Acids Symp Ser (Oxf); 2008; (52):163-4. PubMed ID: 18776304
[TBL] [Abstract][Full Text] [Related]
12. Cross-links of quadruplex structures from human telomeric DNA by dinuclear platinum complexes show the flexibility of both structures.
Ourliac-Garnier I; Elizondo-Riojas MA; Redon S; Farrell NP; Bombard S
Biochemistry; 2005 Aug; 44(31):10620-34. PubMed ID: 16060671
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA.
Malina J; Natile G; Brabec V
Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652
[TBL] [Abstract][Full Text] [Related]
14. Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I-cathepsin B inhibition.
Albert J; Bosque R; Crespo M; Granell J; López C; Martín R; González A; Jayaraman A; Quirante J; Calvis C; Badía J; Baldomà L; Font-Bardia M; Cascante M; Messeguer R
Dalton Trans; 2015 Aug; 44(30):13602-14. PubMed ID: 26140359
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure.
Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S
Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498
[TBL] [Abstract][Full Text] [Related]
16. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
Cerè V; Grossi L; Munari D; Pollicino S; Martelli L; Martelli M
Anticancer Res; 2006; 26(3A):1815-9. PubMed ID: 16827112
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
18. Anticancer C,N-cycloplatinated(II) complexes containing fluorinated phosphine ligands: synthesis, structural characterization, and biological activity.
Cutillas N; Martínez A; Yellol GS; Rodríguez V; Zamora A; Pedreño M; Donaire A; Janiak C; Ruiz J
Inorg Chem; 2013 Dec; 52(23):13529-35. PubMed ID: 24229419
[TBL] [Abstract][Full Text] [Related]
19. Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines.
Kido Y; Khokhar AR; Siddik ZH
Anticancer Drugs; 1993 Apr; 4(2):251-8. PubMed ID: 8490203
[TBL] [Abstract][Full Text] [Related]
20. New trans-platinum drugs with phosphines and amines as carrier ligands induce apoptosis in tumor cells resistant to cisplatin.
Ramos-Lima FJ; Quiroga AG; García-Serrelde B; Blanco F; Carnero A; Navarro-Ranninger C
J Med Chem; 2007 May; 50(9):2194-9. PubMed ID: 17407274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
